Diabetes – Off-patent medicines can start a virtuous circle of high-quality treatments and better prevention

Open

Delivering best access to care for people with chronic diseases

Open

Respiratory diseases – Value Added Medicines help improve therapy adherence to deliver better health outcomes for patients

Open

Cardiovascular diseases – More patients are being treated while the sustainability of the healthcare system remains ensured

Open

Covid policy paper 2022 – Lessons learned

Medicines for Europe letter to EC on Divisionals & Patent Linkage re Fingolimod – 13.04.2022

Open

Open Public Consultation on the revision of EU rules on medicines for children and rare diseases

Open

The Issue of Abuses of Divisional Patent Application

Open

Заповнення прогалини: Filling the gap – Ukrainian translation now available.

Filling the gap – how off-patent medicines can improve the equity and quality of cancer care – Ukrainian translation now available.

Open Ukrainian translation

Medicines for Europe Position on IP Action Plan – March 2021

Open

Medicines For Europe